Loading clinical trials...
Loading clinical trials...
The purpose of this research study is to confirm the safety and effectiveness of aripiprazole therapy over 12 weeks in subjects with bipolar disorder experiencing symptoms of mania.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Collaborators
NCT07140913 · Mania, Bipolar Disorder
NCT07172516 · Bipolar Disorder, Bipolar Depression, and more
NCT06370988 · Bipolar Depression, Bipolar Disorder, and more
NCT04480918 · Treatment Resistant Depression, Major Depressive Episode, and more
NCT07404085 · Bipolar Disorder (BD), Depression - Major Depressive Disorder, and more
Local Institution
Anaheim, California
Local Institution
Cerritos, California
Local Institution
Garden Grove, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions